Insider · CIK 0001576145
David J Schlanger
Files at PGNY (Progyny, Inc.). First filing Dec 18, 2023, latest Dec 26, 2024.
In brief
David J Schlanger files SEC Form 4 as chair and director at PGNY (Progyny, Inc.). Since Dec 18, 2023, David J Schlanger has reported 1 open-market buy worth $2.2M and 3 open-market sells worth $12M, the latest filed on Dec 26, 2024.
A track record needs three past buys with six months of prices behind them; David J Schlanger has 1, so none is measured yet.
The newest scored trade: bought $2.2M of PGNY on Dec 26, 2024, filed Dec 26, 2024, scored 63 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PGNY: Progyny, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 63Notable | Progyny, Inc. | $2.2M 150,000 shares | +192% | - | |
| 30Weak | Progyny, Inc. | $5.9M 156,031 shares | -93% | +35% from low-12% from high | |
| 38Weak | Progyny, Inc. | $6.2M 162,906 shares | -178% | +29% from low-15% from high | |
| 6Weak | Progyny, Inc. | $40k 1,063 shares | -1% | +27% from low-16% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 5, 2024 | PGNY Progyny Inc | 260,000 0.28% of outstanding | $10M | Feb 5, 2024 | $17M |
| Dec 14, 2023 | PGNY Progyny Inc | 560,000 0.58% of outstanding | $20M | Dec 14, 2023 | none |
Transactions
Every row this insider has filed, 27 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | PGNY Progyny, Inc. | FTax withholding Common Stock | -2,171 | $25.68 | $56k | 238,462 | Jan 5, 2026 |
| Nov 10, 2025 | PGNY Progyny, Inc. | AGrant or award Common Stock | +41,500 | $0.00 | $0 | 261,919 | Nov 13, 2025 |
| Nov 10, 2025 | PGNY Progyny, Inc. | FTax withholding Common Stock | -21,286 | $22.37 | $476k | 240,633 | Nov 13, 2025 |
| Oct 1, 2025 | PGNY Progyny, Inc. | FTax withholding Common Stock | -1,893 | $21.52 | $41k | 220,419 | Oct 2, 2025 |
| Jul 1, 2025 | PGNY Progyny, Inc. | FTax withholding Common Stock | -1,893 | $22.00 | $42k | 222,312 | Jul 2, 2025 |
| Apr 1, 2025 | PGNY Progyny, Inc. | FTax withholding Common Stock | -1,893 | $22.34 | $42k | 224,205 | Apr 3, 2025 |
| Dec 26, 2024 | PGNY Progyny, Inc. | POpen-market purchase Common Stock | +150,000 | $14.68 | $2.2M | 228,269 | Dec 26, 2024 |
| Dec 26, 2023 | PGNY Progyny, Inc. | MOption exercise Common Stock10b5-1 | +80,000 | $3.95 | $316k | 168,439 | Dec 28, 2023 |
| Dec 26, 2023 | PGNY Progyny, Inc. | SOpen-market sale Common Stock10b5-1 | -80,000 | $37.93 | $3.0M | 88,439 | Dec 28, 2023 |
| Dec 27, 2023 | PGNY Progyny, Inc. | MOption exercise Common Stock10b5-1 | +76,031 | $3.95 | $301k | 164,470 | Dec 28, 2023 |
| Dec 27, 2023 | PGNY Progyny, Inc. | SOpen-market sale Common Stock10b5-1 | -76,031 | $37.66 | $2.9M | 88,439 | Dec 28, 2023 |
| Dec 26, 2023 | PGNY Progyny, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -80,000 | $0.00 | $0 | 1,626,053 | Dec 28, 2023 |
| Dec 27, 2023 | PGNY Progyny, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -76,031 | $0.00 | $0 | 1,550,022 | Dec 28, 2023 |
| Dec 20, 2023 | PGNY Progyny, Inc. | MOption exercise Common Stock10b5-1 | +2,906 | $3.95 | $11k | 91,345 | Dec 22, 2023 |
| Dec 20, 2023 | PGNY Progyny, Inc. | SOpen-market sale Common Stock10b5-1 | -2,906 | $37.50 | $109k | 88,439 | Dec 22, 2023 |
| Dec 21, 2023 | PGNY Progyny, Inc. | MOption exercise Common Stock10b5-1 | +80,000 | $3.95 | $316k | 168,439 | Dec 22, 2023 |
| Dec 21, 2023 | PGNY Progyny, Inc. | SOpen-market sale Common Stock10b5-1 | -80,000 | $37.65 | $3.0M | 88,439 | Dec 22, 2023 |
| Dec 22, 2023 | PGNY Progyny, Inc. | MOption exercise Common Stock10b5-1 | +80,000 | $3.95 | $316k | 168,439 | Dec 22, 2023 |
| Dec 22, 2023 | PGNY Progyny, Inc. | SOpen-market sale Common Stock10b5-1 | -80,000 | $38.11 | $3.0M | 88,439 | Dec 22, 2023 |
| Dec 20, 2023 | PGNY Progyny, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,906 | $0.00 | $0 | 1,866,053 | Dec 22, 2023 |
| Dec 21, 2023 | PGNY Progyny, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -80,000 | $0.00 | $0 | 1,786,053 | Dec 22, 2023 |
| Dec 22, 2023 | PGNY Progyny, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -80,000 | $0.00 | $0 | 1,706,053 | Dec 22, 2023 |
| Dec 14, 2023 | PGNY Progyny, Inc. | MOption exercise Common Stock10b5-1 | +1,063 | $3.95 | $4,204 | 89,502 | Dec 18, 2023 |
| Dec 14, 2023 | PGNY Progyny, Inc. | SOpen-market sale Common Stock10b5-1 | -1,063 | $37.53 | $40k | 88,439 | Dec 18, 2023 |
| Dec 14, 2023 | PGNY Progyny, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,063 | $0.00 | $0 | 1,868,959 | Dec 18, 2023 |
| Nov 20, 2023 | PGNY Progyny, Inc. | AGrant or award Common Stock | +41,500 | $0.00 | $0 | 109,625 | Nov 22, 2023 |
| Nov 20, 2023 | PGNY Progyny, Inc. | FTax withholding Common Stock | -21,186 | $32.20 | $682k | 88,439 | Nov 22, 2023 |
Questions about David J Schlanger
Answered from the filings on this page, as of the latest one.
Is David J Schlanger buying or selling?
Not in the last 12 months. David J Schlanger's latest open-market trade on SEC Form 4 was bought $2.2M of PGNY on Dec 26, 2024.
How did David J Schlanger's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David J Schlanger has 1.
Where does David J Schlanger file Form 4?
David J Schlanger has filed Form 4 at PGNY (Progyny, Inc.) as Executive Chairman. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.